Glaucoma Research Foundation's one-year Shaffer Grants place an emphasis on projects that explore new ideas in the realm of glaucoma research, especially innovative ideas that would otherwise not have been pursued.
Read More »
Glaucoma is a complex disease in which damage to the optic nerve leads to progressive vision loss. Currently, there is no way to restore vision lost to glaucoma. At Glaucoma Research Foundation, our mission is to cure glaucoma and restore...
Read More »
Glaucoma Research Foundation Shaffer Grants present a unique opportunity for investigators to pursue innovative ideas in the spirit of high risk/high reward scientific discovery. An emphasis is placed on projects that explore new ideas in the realm of glaucoma research....
Read More »
Whatever curves life throws at us, I believe one must always make the best out of a situation; there is always a positive side. After my experiences with uveitis, glaucoma, operations, sight loss, medicine routines, and changing ways of life,...
Read More »
In 2016 while completing my law degree in Jamaica, I had a unique and strange headache. The pain was on and off, but the headache seemed to center around my eyes. As a busy student, I chose to ignore it....
Read More »
In my personal experience with having glaucoma and being visually impaired, at some point in my life, I will have to use Braille. When I was a young child, I thought that Braille didn’t apply to me and it was...
Read More »
Glaucoma is a worldwide problem that can lead to blindness. It is especially problematic because there are often no symptoms in its early stages and although certain groups are at higher risk than others, everyone, at any age, is at...
Read More »
Glaucoma, the leading cause of irreversible blindness, is a complicated disease in which damage to the optic nerve leads to progressive vision loss. Today, more than 3 million Americans are living with glaucoma, and this number is expected to double...
Read More »
More than 50 companies and institutions were featured during a full day of presentations, panels, and discussions with leaders from start-up companies, industry executives, ophthalmic experts, venture capitalists, and the FDA.
Read More »
Whenever a new Apple product is released, the media hype is immense and people will camp out for days just to be the first to own one. Ophthalmology is never going to be as interesting as iPhones but in our...
Read More »
